Agrypnia excitata: current concepts and future prospects in management.
Agrypnia excitata is an extremely rare, life-threatening syndrome characterized by autonomic activation, persistent insomnia, and generalized overactivity. Agrypnia excitata describes a triad of three separate conditions: delirium tremens, Morvan's chorea, and familial fatal insomnia (FFI). Each of the aforementioned three conditions have sleep disturbances as a unifying theme and results in distinct neurophysiological findings. The following is an overview of agrypnia excitata with a particular emphasis placed upon each of the three individual conditions that constitute the syndrome with recommendations on appropriate management.
Hazin
Ribhi
R
Faculty of Arts and Sciences, Harvard University, USA.
Abuzetun
Jamil Y
JY
Giglio
Pierre
P
Khan
Faisal
F
D001342:Autonomic Nervous System Diseases / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D003072:Cognition Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D019468:Disease Management; D005544:Forecasting; D006801:Humans; D034062:Insomnia, Fatal Familial / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D020385:Myokymia / Q000175:diagnosis / Q000523:psychology / Q000628:therapy